Form 4: Biora Therapeutics Officer Clarke Neumann Reports Tax-Related Stock Disposal

Clarke Neumann, an officer at Biora Therapeutics, disposed of 26,629 shares to cover tax obligations related to vested restricted stock units.

Summary

• On August 15, 2024, Clarke Neumann, an officer of Biora Therapeutics, disposed of 26,629 shares of common stock.
• The shares were withheld by the issuer to satisfy tax withholding obligations related to the vesting of restricted stock units.
• The transaction was executed at a price of $0.67 per share.
• Following the transaction, Neumann directly owns 465,564 shares of Biora Therapeutics.

Sentiment

Score: 5

Explanation: The Form 4 filing itself is a neutral event. It simply reports a transaction. The disposal of shares for tax purposes is a routine occurrence.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's stock.

Key Dates

Keywords

Form 4, Biora Therapeutics, Clarke Neumann, Stock Disposal, Tax Withholding, Restricted Stock Units, Beneficial Ownership